title: Medians and Milestones in Describing the Path to Cancer Cures: Telling "Tails".
authors.affiliation: Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York2Weill Cornell Medical College, New York, New York.
authors.forename: Matthew D
authors.initials: MD
authors.lastname: Hellmann
authors.affiliation: Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York2Weill Cornell Medical College, New York, New York.
authors.forename: Mark G
authors.initials: MG
authors.lastname: Kris
authors.affiliation: Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York2Weill Cornell Medical College, New York, New York.
authors.forename: Charles M
authors.initials: CM
authors.lastname: Rudin
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003627:Data Interpretation, Statistical; D055808:Drug Discovery / Q000706:statistics & numerical data*; D023381:Endpoint Determination; D006801:Humans; D008495:Medical Oncology / Q000706:statistics & numerical data*; D009369:Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D012074:Remission Induction; D012107:Research Design / Q000706:statistics & numerical data*; D016019:Survival Analysis; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents